Lamotrigin Desitin

Lamotrigine, the active ingredient in Lamotrigin Desitin, is a sodium channel blocker presented as an oral formulation for oral use. It is employed to manage seizure disorders and mood stabilization in bipolar disorder, and is indicated for specific epilepsy syndromes such as Lennox‑Gastaut and is approved for use in the European Union.

GNH USA supplies Lamotrigin Desitin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets.

Lamotrigine is used to treat disorders that involve abnormal neuronal excitability, primarily within the seizure and mood disorder categories. - Epilepsy: reduces seizure frequency and severity in focal and generalized seizure types. - Bipolar disorder: stabilizes mood and decreases the risk of manic or depressive episodes. - Lennox‑Gastaut syndrome: helps control multiple seizure types in this severe childhood epilepsy.

Lamotrigine may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness - Headache - Nausea - Rash

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe skin reactions such as DRESS (drug reaction with eosinophilia and systemic symptoms) - Aseptic meningitis

When prescribing lamotrigine, clinicians should observe several safety measures. - Initiate therapy at low dose: start with a low dose and increase gradually to reduce rash risk. - Monitor skin reactions: discontinue immediately if a serious rash develops. - Assess hepatic function: use caution in patients with liver impairment. - Review concomitant valproate: dose adjustments may be needed when combined with enzyme‑inhibiting drugs. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and light.

Lamotrigine interacts with several medicines that can alter its plasma concentration or increase toxicity risk.

Major Interactions (Avoid): - Valproic acid: can markedly increase lamotrigine levels, raising toxicity risk. - Carbamazepine: reduces lamotrigine concentrations, potentially decreasing efficacy.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may lower lamotrigine levels, requiring dose adjustment. - Phenobarbital: may decrease lamotrigine exposure. - Serotonergic agents: combined use may increase risk of serotonin syndrome, though evidence is limited.